Oramed Pharmaceuticals Inc

ORMPNASDAQ · USD
4.74USD0.00 (+1.50%)
8110

Oramed Pharmaceuticals Inc (ORMP) Option Chain

As of September 18, 2026, Oramed Pharmaceuticals Inc is trading at $4.74, a +1.50% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 115.4%. IV Rank is 23%.

Read more

Tracking the ORMP option chain helps you see every strike and expiry on Oramed Pharmaceuticals Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Oramed Pharmaceuticals Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of ORMP options activity at a glance. Use our scanner to monitor the ORMP option chain in real time and filter for the ORMP options trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For ORMP stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the ORMP option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where ORMP stock options are being actively traded and where they are not.

Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for the treatment of individuals with diabetes. It is also developing ORMD-0901, an oral glucagon-like peptide-1 capsule that has completed phase I clinical trials for the treatment of type 2 diabetes; and a weight loss treatment in the form of an oral leptin capsule.

The company was formerly known as Integrated Security Technologies, Inc. and changed its name to Oramed Pharmaceuticals Inc. in April 2006. Oramed Pharmaceuticals Inc. was founded in 2002 and is based in New York, New York.

Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Oramed Pharmaceuticals Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen ORMP options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of ORMP stock options — let the full option chain come to you, pre-filtered and ready to trade.

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV percentile30.16% Subdued
  • Market cap (M$)197
  • 52 weeks high-13.35%
  • 52 weeks low126.79%
  • Analyst recommendationHold
    3.00
  • Target price$7.00
    47.68% above the current stock price
  • Dividend
  • Payout ratio0.00%
  • Earnings date2026-11-12
  • P/E1.15
  • Future P/E
  • EPS (ttm)4.11
  • EPS growth next 5 years

As of September 18, 2026

2026-10-16
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
2.99000.062.240.204.402.50-47.262.150.002.150197.01
62.46300.650.000.655.00+5.492.600.262.340037.54
94.57002.150.002.157.50+58.230.704.902.760.04005.43

As of September 18, 2026

Scan the full option chain in one place

Browse the full ORMP option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.

Start your 14-day free trial